Cetuximab Rechallenge Study

Clinical trial NCT01832467 · COMPLETED

Trial details

NCT number: NCT01832467
Sponsor: Chinese University of Hong Kong
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2013-04-24
Primary completion: 2020-04-07
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.